Tyra Biosciences (TYRA) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 28, 2026, to be held virtually for stockholders of record as of April 2, 2026.

• Meeting materials include the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K.

Voting matters and shareholder proposals

• Election of three Class II directors for a three-year term expiring at the 2029 annual meeting: Habib J. Dable, Susan Moran, and Robert More.

• Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Other business may be transacted as properly brought before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends a vote in favor of both director election and auditor ratification proposals.